<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Kuznar, Wayne</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Workman, Paul</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Notable Developments in Genomic Profiling Have Enhanced Personalized Cancer Care</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-07-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">29-31</style></pages><abstract><style  face="normal" font="default" size="100%">Tumor genomic profiling in clinical studies and the integration of tumor genomics into clinical practice are rapidly becoming the standard of care. This article discusses methods to apply genomics to guide clinical investigation, next-generation sequencing, how homologous recombination acts as a target and as a predictive and prognostic biomarker, and the therapeutic dissection of lung cancer.</style></abstract><number><style face="normal" font="default" size="100%">14</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>